Dr Habeebullah Life Sciences Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2018 Mar-2017 - -
Growth matrix (%)        
Revenue growth (52) -- -- --
Op profit growth 92.90 -- -- --
EBIT growth 90 -- -- --
Net profit growth (20) -- -- --
Profitability ratios (%)        
OPM (183) (46) -- --
EBIT margin (180) (46) -- --
Net profit margin (170) (102) -- --
RoCE (5.40) -- -- --
RoNW (2.70) -- -- --
RoA (1.30) -- -- --
Per share ratios ()        
EPS -- -- -- --
Dividend per share -- -- -- --
Cash EPS (0.90) (1.30) -- --
Book value per share 9.66 7.67 -- --
Valuation ratios        
P/E -- -- -- --
P/CEPS (51) (11) -- --
P/B 4.77 1.79 -- --
EV/EBIDTA (55) (36) -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (5.60) 124 -- --
Liquidity ratios        
Debtor days 1,817 -- -- --
Inventory days 29.60 -- -- --
Creditor days (10) -- -- --
Leverage ratios        
Interest coverage -- -- -- --
Net debt / equity 0.57 0.82 -- --
Net debt / op. profit (5.70) (11) -- --
Cost breakup ()        
Material costs (10) (97) -- --
Employee costs (145) (27) -- --
Other costs (127) (22) -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2018 Mar-2017 - -
Revenue 0.62 1.28 -- --
yoy growth (%) (52) -- -- --
Raw materials (0.10) (1.20) -- --
As % of sales 10.40 97 -- --
Employee costs (0.90) (0.30) -- --
As % of sales 145 26.60 -- --
Other costs (0.80) (0.30) -- --
As % of sales 127 22 -- --
Operating profit (1.10) (0.60) -- --
OPM (183) (46) -- --
Depreciation -- -- -- --
Interest expense -- -- -- --
Other income 0.03 0.01 -- --
Profit before tax (1.10) (0.60) -- --
Taxes 0.06 (0.70) -- --
Tax rate (5.60) 124 -- --
Minorities and other -- -- -- --
Adj. profit (1) (1.30) -- --
Exceptional items -- -- -- --
Net profit (1) (1.30) -- --
yoy growth (%) (20) -- -- --
NPM (170) (102) -- --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2018 Mar-2017 - -
Profit before tax (1.10) (0.60) -- --
Depreciation -- -- -- --
Tax paid 0.06 (0.70) -- --
Working capital 0.92 -- -- --
Other operating items -- -- -- --
Operating cashflow (0.10) -- -- --
Capital expenditure 0.02 -- -- --
Free cash flow (0.10) -- -- --
Equity raised (0.20) -- -- --
Investments -- -- -- --
Debt financing/disposal 13.30 -- -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 12.90 -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2019 Mar-2018 Mar-2017 -
Equity capital 14.30 13.30 10.30 --
Preference capital -- -- -- --
Reserves (2.10) (1.90) (2.40) --
Net worth 12.20 11.40 7.87 --
Minority interest
Debt 7.92 6.81 6.50 --
Deferred tax liabilities (net) -- -- -- --
Total liabilities 24.20 22.30 18.50 --
Fixed assets 18 16.50 15.30 --
Intangible assets
Investments 0.01 0.01 0.01 --
Deferred tax asset (net) 0.39 0.36 0.30 --
Net working capital 5.72 5.09 2.86 --
Inventories 0.16 0.10 -- --
Inventory Days -- 59.20 -- --
Sundry debtors 2.21 2.87 3.27 --
Debtor days -- 1,699 932 --
Other current assets 5.41 2.72 0.32 --
Sundry creditors (0.20) (0.10) -- --
Creditor days -- 35.50 11.40 --
Other current liabilities (1.80) (0.50) (0.70) --
Cash 0.02 0.34 0.03 --
Total assets 24.20 22.30 18.50 --
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2020 Mar-2019 Mar-2018 Mar-2017 -
Gross Sales 1.43 2.01 0.62 1.28 --
Excise Duty -- -- -- -- --
Net Sales 1.43 2.01 0.62 1.28 --
Other Operating Income -- -- -- -- --
Other Income 0.16 0.11 0.03 0.01 --
Total Income 1.59 2.12 0.64 1.29 --
Total Expenditure ** 3.63 4.46 1.74 1.87 --
PBIDT (2) (2.30) (1.10) (0.60) --
Interest -- -- -- -- --
PBDT (2) (2.30) (1.10) (0.60) --
Depreciation 0.02 0.02 0.01 0.01 --
Minority Interest Before NP -- -- -- -- --
Tax -- -- -- -- --
Deferred Tax (0.10) -- (0.10) 0.72 --
Reported Profit After Tax (2) (2.30) (1.10) (1.30) --
Minority Interest After NP -- -- -- (0.50) --
Net Profit after Minority Interest (2) (2.30) (1) (0.80) --
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item (2) (2.30) (1) (0.80) --
EPS (Unit Curr.) (1.30) (1.80) (1) (1.10) --
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 14.80 13.80 11.80 10.30 --
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) (143) (116) (177) (45) --
PBDTM(%) (143) (116) (177) (45) --
PATM(%) (138) (116) (169) (102) --